Evaluation of protein degradation by new proteolysis targeting chimera in human cervical adenocarcinoma epithelial cells and an in vivo mouse model

Key Points

• Protein degradation varies significantly in human cervical adenocarcinoma cells, suggesting targeted treatments may be effective.
• The study shows that using a new proteolysis targeting chimera leads to enhanced degradation of specific proteins in the cancer cells.
• Analysis across both in vitro human epithelial cells and an in vivo mouse model highlights the method's applicability.
• The findings may enable new approaches in cancer therapy, particularly for treating adenocarcinoma, though in vivo validation is needed.